Inventor · disambiguated record
Petr Ilyinskii
Also filed as: ILYINSKII PETR · ILYINSKII PETR O
4 granted patents·18 pending applications·88 citations·filing 2002–2023
79Inventor score
Files withSELECTA BIOSCIENCES INC13ILYINSKII PETR6ALTREUTER DAVID H1CASTOR TREVOR P1ILYINSKII PETR O1
Top patents by PatentIndex Score
22 records- 0196US9764031B2Dose selection of adjuvanted synthetic nanocarriersSELECTA BIOSCIENCES INC·Filed 2015·Granted Sep 19, 2017·35 cites·18 claims
- 0292US9066978B2Dose selection of adjuvanted synthetic nanocarriersILYINSKII PETR·Filed 2011·Granted Jun 30, 2015·35 cites·11 claims
- 0381US10933129B2Methods for administering synthetic nanocarriers that generate humoral and cytotoxic T lymphocyte responsesALTREUTER DAVID H·Filed 2012·Granted Mar 2, 2021·6 cites·19 claims
- 0481US7033813B2Inactivated vaccines for aids and other infectious diseasesCASTOR TREVOR P·Filed 2002·Granted Apr 25, 2006·12 cites·13 claims
- 0563US2023322884A1Immunosuppressant in combination with high affinity il-2 receptor agonists and related dosingSELECTA BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 0663US2023357437A1Immunosuppressants in combination with anti-igm agents and related dosingSELECTA BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 0763US2023381277A1High affinity il-2 receptor agonists and immunosuppressants to enhance immune toleranceSELECTA BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 0861US2023141563A1Methods and compositions for attenuating anti-viral transfer vector igm responsesSELECTA BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 0959US2022323607A1Synthetic nanocarriers comprising an immunosuppressant in combination with high affinity il-2 receptor agonists to enhance immune toleranceSELECTA BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 1056US2012058153A1Synthetic nanocarrier vaccines comprising proteins obtained or derived from human influenza a virus hemagglutininILYINSKII PETR·Filed 2011·Application pending·0 cites
- 1155US2012064110A1Synthetic nanocarrier vaccines comprising peptides obtained or derived from human influenza a virus hemagglutininILYINSKII PETR·Filed 2011·Application pending·0 cites
- 1254US2020390718A1Methods and compositions for attenuated anti-viral transfer vector immune responseSELECTA BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 1354US2020360453A1Methods for treatment of subjects with preexisting immunity to viral transfer vectorsSELECTA BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 1454US2021154324A1Methods and compositions for treating liver diseases and disordersSELECTA BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 1552US2021290601A1Methods and compositions using synthetic nanocarriers comprising immunosuppressantSELECTA BIOSCIENCES INC·Filed 2021·Application pending·0 cites
- 1652US2012058154A1Synthetic nanocarrier vaccines comprising peptides obtained or derived from human influenza a virus m2eILYINSKII PETR·Filed 2011·Application pending·0 cites
- 1750US2018043023A1Dose selection of adjuvanted synthetic nanocarriersILYINSKII PETR·Filed 2017·Application pending·0 cites
- 1850US2023147052A1Methods and compositions for inducing autophagySELECTA BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 1944US2018193482A1Patterned dosing of immunosuppressants coupled to synthetic nanocarriersILYINSKII PETR·Filed 2018·Application pending·0 cites
- 2043US2019142974A1Methods and compositions for attenuating anti-viral transfer vector igm responsesSELECTA BIOSCIENCES INC·Filed 2018·Application pending·0 cites
- 2143US2018071394A1Polyester polymer matrices for the delivery of allergensSELECTA BIOSCIENCES INC·Filed 2017·Application pending·0 cites
- 2238US2012177701A1Compositions comprising immunostimulatory nucleic acids and related methodsILYINSKII PETR O·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Petr Ilyinskii files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →